Since compound 0375-0604 significantly inhibited cell viability of NSCLC cells with KRAS mutation, we examined whether compound 0375-0604 exhibited cytotoxicity by cell cycle arrest or apoptotic effect in H2122, H358 and H460 cells. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.